\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ nasal\\ mass\\,\\ diplopia\\ on\\ confrontational\\ testing\ \(1\)\
\-\ chemotherapy\ \(327\)\
\-\ mass\\ in\\ right\\ maxillary\\ sinus\\ with\\ erosion\\ through\\ inferior\\ orbital\\ floor\\/maxillary\\ roof\\,\\ with\\ extension\\ into\\ infero\\-medial\\ orbital\\ fat\\ of\\ right\\ orbit\\.\ \(0\)\
\-\ secondary\\ orbital\\ large\\ cell\\ lymphoma\\,\\ extraconal\\ masses\ \(0\)\
\-\ aggressive\\ lymphoma\ \(1\)\
\-\ squamous\\ cell\\ carcinoma\ \(52\)\
\-\ adenocarcinoma\ \(192\)\
\-\ primary\\ melanoma\ \(3\)\
\-\ inverting\\ papilloma\ \(2\)\
\-\ several\\ months\\ history\\ of\\ right\\ nasal\\ congestion\\ and\\ increasing\\ diplopia\\,\\ od\\.\ \(0\)\
\-\ this\\ was\\ an\\ aggressive\\ nhl\\ which\\ originated\\ in\\ the\\ right\\ maxillary\\ sinus\\ and\\ \\(uncharacteristically\\)\\ eroded\\ through\\ the\\ sinus\\ wall\\.\\ invading\\ the\\ right\\ extra\\-conal\\ orbit\\,\\ with\\ evident\\ mass\\ effect\\ on\\ the\\ right\\ globe\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ maxillary\\:\\ 0\\.3216470750835748\ \(0\)\
\-\ orbital\\:\\ 0\\.28450009317820973\ \(0\)\
\-\ right\\:\\ 0\\.25091797290733386\ \(0\)\
\-\ sinus\\:\\ 0\\.2343749197510861\ \(0\)\
\-\ diplopia\\:\\ 0\\.22613460194144291\ \(0\)\
\-\ orbit\\:\\ 0\\.20026493644533983\ \(0\)\
\-\ nasal\\:\\ 0\\.19713681663796387\ \(0\)\
\-\ aggressive\\:\\ 0\\.18698983263370156\ \(0\)\
\-\ uncharacteristically\\:\\ 0\\.17290341974350368\ \(0\)\
\-\ confrontational\\:\\ 0\\.16521844821025933\ \(0\)\
\-\ nhl\\:\\ 0\\.14915921202188306\ \(0\)\
\-\ originated\\:\\ 0\\.14439593106721918\ \(0\)\
\-\ extraconal\\:\\ 0\\.1423989834942548\ \(0\)\
\-\ inverting\\:\\ 0\\.1423989834942548\ \(0\)\
\-\ eroded\\:\\ 0\\.13742626977992112\ \(0\)\
\-\ lymphoma\\:\\ 0\\.12878133178312567\ \(0\)\
\-\ through\\:\\ 0\\.12871954375998917\ \(0\)\
\-\ od\\:\\ 0\\.12580581138087207\ \(0\)\
\-\ invading\\:\\ 0\\.12580581138087207\ \(0\)\
\-\ mass\\:\\ 0\\.12389399633279721\ \(0\)\
\-\ cell\\:\\ 0\\.12369638247448415\ \(0\)\
\-\ roof\\:\\ 0\\.11660375263688098\ \(0\)\
\-\ globe\\:\\ 0\\.1126682657710763\ \(0\)\
\-\ congestion\\:\\ 0\\.10692183353067222\ \(0\)\
\-\ melanoma\\:\\ 0\\.10096572204709926\ \(0\)\
\-\ erosion\\:\\ 0\\.10033737261727205\ \(0\)\
\-\ papilloma\\:\\ 0\\.09913991308067095\ \(0\)\
\-\ squamous\\:\\ 0\\.09729832270458758\ \(0\)\
\-\ testing\\:\\ 0\\.0971236350910379\ \(0\)\
\-\ evident\\:\\ 0\\.09292909901864052\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.08836819792084702\ \(0\)\
\-\ the\\:\\ 0\\.08629343540504554\ \(0\)\
\-\ increasing\\:\\ 0\\.08515144528652782\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.07677057778447298\ \(0\)\
\-\ extension\\:\\ 0\\.07653439439305643\ \(0\)\
\-\ effect\\:\\ 0\\.07584300569132259\ \(0\)\
\-\ masses\\:\\ 0\\.07360432288491169\ \(0\)\
\-\ inferior\\:\\ 0\\.07355411498296696\ \(0\)\
\-\ several\\:\\ 0\\.07093568642449792\ \(0\)\
\-\ fat\\:\\ 0\\.06725575586043837\ \(0\)\
\-\ primary\\:\\ 0\\.06648059879526816\ \(0\)\
\-\ wall\\:\\ 0\\.06576912489624333\ \(0\)\
\-\ on\\:\\ 0\\.06530668161251975\ \(0\)\
\-\ carcinoma\\:\\ 0\\.064671001728663\ \(0\)\
\-\ secondary\\:\\ 0\\.06408396871568289\ \(0\)\
\-\ with\\:\\ 0\\.06351227450391599\ \(0\)\
\-\ months\\:\\ 0\\.06293313215123093\ \(0\)\
\-\ into\\:\\ 0\\.05747340177030884\ \(0\)\
\-\ large\\:\\ 0\\.054172234435154905\ \(0\)\
\-\ in\\:\\ 0\\.0537922502830445\ \(0\)\
\-\ which\\:\\ 0\\.04916210296719081\ \(0\)\
\-\ and\\:\\ 0\\.044682315393366374\ \(0\)\
\-\ of\\:\\ 0\\.042316232397170084\ \(0\)\
\-\ an\\:\\ 0\\.041343769077312936\ \(0\)\
\-\ history\\:\\ 0\\.041307143999441506\ \(0\)\
\-\ was\\:\\ 0\\.03768001916239697\ \(0\)\
\-\ this\\:\\ 0\\.037151120035692965\ \(0\)\
